September 2016 - Investor Relations

4D Lifetec AG has successfully closed capital phase B2. All investors, including new investors represent private investors and business angels. The new capital will be used to support the finalization of the instrument and implement an application lab referencing the first clinical data generated in the near future by leading centres of oncology in Europe.